Pablo Halpern joined the faculty of the 7th annual “Health Care Technological Innovation Program-From Idea to Commercialization” @ Tel Aviv University’s Faculty of Management (Dec 9 – 11, 2013).

The session is a 3-day intensive Executive Program for Biotechnology and Medical Device Entrepreneurs and Managers led by top executives from large medical device and Pharma companies as well as top attorneys, venture capitalists, regulators and academic professors from Wharton and MIT.

Pablo will be participating in Session 11: Emerging Markets – Opportunities for Life Science companies.

“The Health Care Technological Innovation Program-From Idea to Commercialization” is a collaboration between The Faculty of Management of Tel-Aviv University, the Israel Life Science Industry Organization (ILSI), LAHAV – Executive Education at the Faculty of management and The Center for Medicine in the Public Interest and International Institute for Biotechnology Entrepreneurship (a non-profit global contribution by Burrill & Company).

More information

More...